Evidence map›Paper›PMID 37452908›Full record

SynthesisJournal of thrombosis and thrombolysis2023

Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials.

Muhammad Ehsan, Uzair Jafar, Momina Butt, Aiman Naveed, Mohammad Umer, Muhammad Ayyan, Biah Mustafa, Rehmat Ullah Awan

Abstract readMeta-AnalysisSystematic ReviewLetter
PubMed Publisher
In one paragraph

Synthesis in Journal of thrombosis and thrombolysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Muhammad Ehsan *Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan. muhammadehsan@kemu.edu.pk.ORCID 0000-0002-6021-2342
Uzair Jafar *Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan.
Momina ButtDivision of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan.
Aiman NaveedDivision of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan.
Mohammad UmerDivision of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan.
Muhammad AyyanDivision of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan.
Biah MustafaDivision of Infectious Diseases, Department of Medicine, King Edward Medical University, Nila Gumbad Chowk, Neela Gumbad, Lahore, Punjab, 54000, Pakistan.
Rehmat Ullah AwanDepartment of Medicine, Ochsner Rush Medical Center, Meridian, MS, USA.
King Edward Medical University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Venous ThromboembolismAnticoagulantsEnoxaparinHumansRandomized Controlled Trials as TopicAnticoagulantsEnoxaparin

Identifiers

PMID37452908
OpenAlexW4384408119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.